{"transactions":[{"id":4635423,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-30T02:00:09.000Z","date":"2026-09-25","kind":"sale","planned":true,"acquired":false,"shares":765,"price":207.3201,"value":158599.8765,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 37,088 restricted stock units."}],"balance_after":51776,"source":{"system":"sec-edgar","filing":"0001969082-26-000011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000196908226000011/ownership.xml","form_type":"4"}},{"id":4624338,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-18T22:01:03.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":3314,"price":199.3032,"value":660490.8048,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 37,088 restricted stock units."}],"balance_after":52541,"source":{"system":"sec-edgar","filing":"0001969082-26-000009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000196908226000009/ownership.xml","form_type":"4"}},{"id":4624337,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-09-18T22:01:03.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":52,"price":195.0087,"value":10140.4524,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $195.00 to $195.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":55855,"source":{"system":"sec-edgar","filing":"0001969082-26-000009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000196908226000009/ownership.xml","form_type":"4"}},{"id":675805,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"exercise","planned":true,"acquired":false,"shares":26600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 1, 2022 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":3500,"derivative":{"exercise_price":21.61,"expiration_date":"2032-08-31","underlying":"Common Stock","underlying_shares":26600},"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675804,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"exercise","planned":true,"acquired":false,"shares":29680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."}],"balance_after":0,"derivative":{"exercise_price":18.56,"exercise_date":"2026-03-01","expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":29680},"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675803,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":3314,"price":212.0583,"value":702761.2062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades in prices ranging from $211.77 to $212.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,514 restricted stock units."}],"balance_after":55907,"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675802,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":211.3417,"value":951037.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades in prices ranging from $210.77 to $211.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,514 restricted stock units."}],"balance_after":59221,"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675801,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":2540,"price":210.2647,"value":534072.338,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades in prices ranging from $209.77 to $210.72, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,514 restricted stock units."}],"balance_after":63721,"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675800,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":25817,"price":209.2497,"value":5402199.5049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades in prices ranging from $208.77 to $209.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,514 restricted stock units."}],"balance_after":66261,"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675799,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":17323,"price":208.3688,"value":3609572.7224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $207.765 to $208.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":92078,"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675798,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":3400,"price":207.2363,"value":704603.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $206.76 to $207.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,514 restricted stock units."}],"balance_after":109401,"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675797,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"exercise","planned":true,"acquired":true,"shares":26600,"price":21.61,"value":574826.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,514 restricted stock units."}],"balance_after":112801,"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":675796,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:49.000Z","date":"2026-08-21","kind":"exercise","planned":true,"acquired":true,"shares":29680,"price":18.56,"value":550860.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,514 restricted stock units."}],"balance_after":86201,"source":{"system":"sec-edgar","filing":"0001610717-26-000388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000388/form4.xml","form_type":"4"}},{"id":731651,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-06-18T20:10:41.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":2157,"price":156.1191,"value":336748.8987,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8251. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 43,514 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 160 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026."}],"balance_after":56521,"source":{"system":"sec-edgar","filing":"0001610717-26-000245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000245/form4.xml","form_type":"4"}},{"id":833133,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-03-19T22:54:43.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":1163,"price":97.44,"value":113322.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,125 RSUs."}],"balance_after":58518,"source":{"system":"sec-edgar","filing":"0001610717-26-000127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000127/form4.xml","form_type":"4"}},{"id":833132,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-03-19T22:54:43.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":1795,"price":99.4804,"value":178567.318,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,125 RSUs."}],"balance_after":59681,"source":{"system":"sec-edgar","filing":"0001610717-26-000127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000127/form4.xml","form_type":"4"}},{"id":865071,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T02:08:00.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":32500,"derivative":{"exercise_price":102.02,"expiration_date":"2036-02-28","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001610717-26-000080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000080/form4.xml","form_type":"4"}},{"id":865070,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-03-04T02:08:00.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 53,269 restricted stock units."}],"balance_after":61476,"source":{"system":"sec-edgar","filing":"0001610717-26-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000080/form4.xml","form_type":"4"}},{"id":931967,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-23T21:31:05.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":908,"price":115.6,"value":104964.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 38,769 restricted stock units."}],"balance_after":46976,"source":{"system":"sec-edgar","filing":"0001610717-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000018/form4.xml","form_type":"4"}},{"id":962825,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-12-18T21:17:37.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":2688,"price":76.8169,"value":206483.8272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 147 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 38,769 restricted stock units."}],"balance_after":47884,"source":{"system":"sec-edgar","filing":"0001610717-25-000424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000424/form4.xml","form_type":"4"}},{"id":992259,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-20T21:23:35.000Z","date":"2025-11-18","kind":"exercise","planned":true,"acquired":false,"shares":13388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."}],"balance_after":0,"derivative":{"exercise_price":42.45,"exercise_date":"2025-03-04","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":13388},"source":{"system":"sec-edgar","filing":"0001610717-25-000383","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000383/form4.xml","form_type":"4"}},{"id":992258,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-11-20T21:23:35.000Z","date":"2025-11-18","kind":"sale","planned":true,"acquired":false,"shares":13388,"price":70.138,"value":939007.544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $70.00 to $70.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,910 restricted stock units."}],"balance_after":50425,"source":{"system":"sec-edgar","filing":"0001610717-25-000383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000383/form4.xml","form_type":"4"}},{"id":992257,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-11-20T21:23:35.000Z","date":"2025-11-18","kind":"exercise","planned":true,"acquired":true,"shares":13388,"price":42.45,"value":568320.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,910 restricted stock units."}],"balance_after":63813,"source":{"system":"sec-edgar","filing":"0001610717-25-000383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000383/form4.xml","form_type":"4"}},{"id":1015720,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-20T20:19:24.000Z","date":"2025-10-17","kind":"exercise","planned":true,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."}],"balance_after":18000,"derivative":{"exercise_price":36.57,"exercise_date":"2024-06-15","expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001610717-25-000368","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000368/form4.xml","form_type":"4"}},{"id":1015719,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-10-20T20:19:24.000Z","date":"2025-10-17","kind":"sale","planned":true,"acquired":false,"shares":12000,"price":55,"value":660000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,910 restricted stock units."}],"balance_after":50425,"source":{"system":"sec-edgar","filing":"0001610717-25-000368","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000368/form4.xml","form_type":"4"}},{"id":1015718,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-10-20T20:19:24.000Z","date":"2025-10-17","kind":"exercise","planned":true,"acquired":true,"shares":12000,"price":36.57,"value":438840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,910 restricted stock units."}],"balance_after":62425,"source":{"system":"sec-edgar","filing":"0001610717-25-000368","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000368/form4.xml","form_type":"4"}},{"id":1031571,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-09-26T20:13:13.000Z","date":"2025-09-24","kind":"sale","planned":true,"acquired":false,"shares":1799,"price":44.26,"value":79623.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,910 restricted stock units."}],"balance_after":50425,"source":{"system":"sec-edgar","filing":"0001610717-25-000353","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000353/form4.xml","form_type":"4"}},{"id":1036121,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-09-18T20:35:53.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":1869,"price":45.8249,"value":85646.7381,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,910 restricted stock units."}],"balance_after":52224,"source":{"system":"sec-edgar","filing":"0001610717-25-000347","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000347/form4.xml","form_type":"4"}},{"id":1103441,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-06-23T20:07:23.000Z","date":"2025-06-20","kind":"sale","planned":true,"acquired":false,"shares":1912,"price":39.6108,"value":75735.8496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $39.26 to $40.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 49,054 restricted stock units."}],"balance_after":54093,"source":{"system":"sec-edgar","filing":"0001610717-25-000250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000250/form4.xml","form_type":"4"}},{"id":1105950,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-06-18T20:06:09.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":1878,"price":39.83,"value":74800.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $39.5915 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 160 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 49,054 RSUs."}],"balance_after":56005,"source":{"system":"sec-edgar","filing":"0001610717-25-000240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000240/form4.xml","form_type":"4"}},{"id":1193123,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-03-24T20:55:57.000Z","date":"2025-03-20","kind":"sale","planned":true,"acquired":false,"shares":2041,"price":38.7105,"value":79008.1305,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $38.49 to $38.91, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 54,195 restricted stock units."}],"balance_after":57723,"source":{"system":"sec-edgar","filing":"0001610717-25-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000088/form4.xml","form_type":"4"}},{"id":1196756,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-03-19T21:43:42.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":1458,"price":39.0403,"value":56920.7574,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,195 RSUs."}],"balance_after":59764,"source":{"system":"sec-edgar","filing":"0001610717-25-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000081/form4.xml","form_type":"4"}},{"id":1226272,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:03:20.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":77000,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001610717-25-000056","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000056/form4.xml","form_type":"4"}},{"id":1226271,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T00:03:20.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 58,204 restricted stock units."}],"balance_after":61222,"source":{"system":"sec-edgar","filing":"0001610717-25-000056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000056/form4.xml","form_type":"4"}},{"id":1297216,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-22T22:30:43.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":2406,"price":40.5,"value":97443.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 36,204 restricted stock units."}],"balance_after":39222,"source":{"system":"sec-edgar","filing":"0001610717-25-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000012/form4.xml","form_type":"4"}},{"id":1326212,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-12-18T21:07:23.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":1599,"price":45.4038,"value":72600.6762,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 147 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 36,204 RSUs."}],"balance_after":41628,"source":{"system":"sec-edgar","filing":"0001610717-24-000544","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000544/form4.xml","form_type":"4"}},{"id":1358356,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-11-19T21:05:09.000Z","date":"2024-11-15","kind":"sale","planned":true,"acquired":false,"shares":2554,"price":55.1337,"value":140811.4698,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $54.91 to $55.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 40,209 restricted stock units."}],"balance_after":43080,"source":{"system":"sec-edgar","filing":"0001610717-24-000525","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000525/form4.xml","form_type":"4"}},{"id":1370833,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-08T21:20:38.000Z","date":"2024-11-06","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."}],"balance_after":30000,"derivative":{"exercise_price":36.57,"exercise_date":"2024-06-15","expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001610717-24-000518","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000518/form4.xml","form_type":"4"}},{"id":1370832,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-11-08T21:20:38.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":60,"value":360000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,209 restricted stock units."}],"balance_after":45634,"source":{"system":"sec-edgar","filing":"0001610717-24-000518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000518/form4.xml","form_type":"4"}},{"id":1370831,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-11-08T21:20:38.000Z","date":"2024-11-06","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":36.57,"value":219420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,209 restricted stock units."}],"balance_after":51634,"source":{"system":"sec-edgar","filing":"0001610717-24-000518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000518/form4.xml","form_type":"4"}},{"id":1386474,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-15T21:29:39.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."}],"balance_after":36000,"derivative":{"exercise_price":36.57,"exercise_date":"2024-06-15","expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001610717-24-000506","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000506/form4.xml","form_type":"4"}},{"id":1386473,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-10-15T21:29:39.000Z","date":"2024-10-11","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":50.1711,"value":301026.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $50.00 to $50.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 40,209 restricted stock units."}],"balance_after":45634,"source":{"system":"sec-edgar","filing":"0001610717-24-000506","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000506/form4.xml","form_type":"4"}},{"id":1386472,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-10-15T21:29:39.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":36.57,"value":219420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 40,209 restricted stock units."}],"balance_after":51634,"source":{"system":"sec-edgar","filing":"0001610717-24-000506","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000506/form4.xml","form_type":"4"}},{"id":1403170,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-09-18T20:16:54.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":1454,"price":44.1853,"value":64245.4262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,209 restricted stock units."}],"balance_after":45634,"source":{"system":"sec-edgar","filing":"0001610717-24-000485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000485/form4.xml","form_type":"4"}},{"id":1456762,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-07-10T20:36:49.000Z","date":"2024-07-09","kind":"sale","planned":true,"acquired":false,"shares":2399,"price":40.83,"value":97951.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 44,217 restricted stock units."}],"balance_after":47088,"source":{"system":"sec-edgar","filing":"0001610717-24-000395","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000395/form4.xml","form_type":"4"}},{"id":1467945,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-06-27T22:48:11.000Z","date":"2024-06-26","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":38.4698,"value":76939.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $38.11 to $38.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 44,217 restricted stock units."}],"balance_after":49487,"source":{"system":"sec-edgar","filing":"0001610717-24-000368","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000368/form4.xml","form_type":"4"}},{"id":1472769,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-06-20T20:11:20.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":1757,"price":37.3874,"value":65689.6618,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $37.3845 to $37.3904, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 370 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 44,217 RSUs."}],"balance_after":51487,"source":{"system":"sec-edgar","filing":"0001610717-24-000348","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000348/form4.xml","form_type":"4"}},{"id":1505058,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-22T20:11:53.000Z","date":"2024-05-21","kind":"sale","planned":true,"acquired":false,"shares":800,"price":39.5061,"value":31604.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $39.22 to $39.88, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 48,972 restricted stock units."}],"balance_after":52874,"source":{"system":"sec-edgar","filing":"0001610717-24-000256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000256/form4.xml","form_type":"4"}},{"id":1505057,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-22T20:11:53.000Z","date":"2024-05-21","kind":"sale","planned":true,"acquired":false,"shares":700,"price":38.6657,"value":27065.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $38.14 to $39.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 48,972 restricted stock units."}],"balance_after":53674,"source":{"system":"sec-edgar","filing":"0001610717-24-000256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000256/form4.xml","form_type":"4"}},{"id":1558205,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-03-28T20:11:58.000Z","date":"2024-03-27","kind":"sale","planned":true,"acquired":false,"shares":800,"price":31.515,"value":25212.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $31.38 to $31.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 48,972 restricted stock units."}],"balance_after":54374,"source":{"system":"sec-edgar","filing":"0001610717-24-000189","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000189/form4.xml","form_type":"4"}},{"id":1558204,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-03-28T20:11:58.000Z","date":"2024-03-27","kind":"sale","planned":true,"acquired":false,"shares":700,"price":30.3843,"value":21269.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $30.16 to $30.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 48,972 restricted stock units."}],"balance_after":55174,"source":{"system":"sec-edgar","filing":"0001610717-24-000189","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000189/form4.xml","form_type":"4"}},{"id":1565695,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-03-20T20:45:50.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":1252,"price":31.5832,"value":39542.1664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 48,972 RSUs."}],"balance_after":55874,"source":{"system":"sec-edgar","filing":"0001610717-24-000174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000174/form4.xml","form_type":"4"}},{"id":1594042,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T21:54:24.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":73500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":73500,"derivative":{"exercise_price":29.8,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":73500},"source":{"system":"sec-edgar","filing":"0001610717-24-000132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000132/form4.xml","form_type":"4"}},{"id":1594041,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-03-05T21:54:24.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,417 restricted stock units."}],"balance_after":57126,"source":{"system":"sec-edgar","filing":"0001610717-24-000132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000132/form4.xml","form_type":"4"}},{"id":1671845,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-01-24T21:12:33.000Z","date":"2024-01-22","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":27,"value":40500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,417 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 342 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2023."}],"balance_after":36126,"source":{"system":"sec-edgar","filing":"0001610717-24-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000040/form4.xml","form_type":"4"}},{"id":1703130,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-12-20T22:08:04.000Z","date":"2023-12-18","kind":"sale","planned":true,"acquired":false,"shares":1229,"price":25.9017,"value":31833.1893,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $25.9017 to $25.915, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 31,417 RSUs."}],"balance_after":37284,"source":{"system":"sec-edgar","filing":"0001610717-23-000414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000414/form4.xml","form_type":"4"}},{"id":1734195,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-11-20T23:24:16.000Z","date":"2023-11-20","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":21.6966,"value":32544.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $21.38 to $22.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 34,860 restricted stock units."}],"balance_after":38513,"source":{"system":"sec-edgar","filing":"0001610717-23-000360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000360/form4.xml","form_type":"4"}},{"id":1770085,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-10-02T20:12:59.000Z","date":"2023-09-28","kind":"sale","planned":true,"acquired":false,"shares":202,"price":29.0599,"value":5870.0998,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $29.05 to $29.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 34,860 restricted stock units."}],"balance_after":40013,"source":{"system":"sec-edgar","filing":"0001610717-23-000300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000300/form4.xml","form_type":"4"}},{"id":1770084,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-10-02T20:12:59.000Z","date":"2023-09-28","kind":"sale","planned":true,"acquired":false,"shares":1798,"price":28.0999,"value":50523.6202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $27.84 to $28.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 34,860 restricted stock units."}],"balance_after":40215,"source":{"system":"sec-edgar","filing":"0001610717-23-000300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000300/form4.xml","form_type":"4"}},{"id":1775966,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-09-20T20:11:43.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":1214,"price":31.3106,"value":38011.0684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $31.1026 to $31.3108, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 34,860 RSUs."}],"balance_after":42013,"source":{"system":"sec-edgar","filing":"0001610717-23-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000293/form4.xml","form_type":"4"}},{"id":1818930,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-08-01T22:23:07.000Z","date":"2023-07-31","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":26.02,"value":39030.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $25.78 to $26.37, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 38,305 restricted stock units."}],"balance_after":43227,"source":{"system":"sec-edgar","filing":"0001610717-23-000219","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000219/form4.xml","form_type":"4"}},{"id":1846167,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19800,"kind":"person","name":"Cislini Jeff","position":1,"cik":"0001969082","reported_name":"Cislini Jeff","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-06-22T20:24:59.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":1239,"price":25.14,"value":31148.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 370 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 38,305 RSUs."}],"balance_after":44727,"source":{"system":"sec-edgar","filing":"0001610717-23-000192","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000192/form4.xml","form_type":"4"}}]}